Patent · US Active

Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation

US9782517B2 · kind B2 · utility

1Cited by

13References

43Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Jacob Pollock · Honolulu, US
Lauren E. Kokai · Midland School, US
Cunqi Cui · Jurupa Valley, US
Xiaojie Yu · Irvine, US
Dennis E. Van Epps · Cary, US
Darin J. Messina · Somerville, US

Key dates

Filing date	Apr 24, 2017
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Apr 24, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hydrogels comprising a macromolecular matrix and water may be used to augment soft tissue of a human being, promote or support cell or tissue viability or proliferation, create space in tissue, and for other purposes. A macromolecular matrix may comprise a hyaluronic acid component crosslinked to a collagen component.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.